G
Gulay Asci
Researcher at Ege University
Publications - 106
Citations - 3562
Gulay Asci is an academic researcher from Ege University. The author has contributed to research in topics: Transplantation & Blood pressure. The author has an hindex of 28, co-authored 98 publications receiving 3091 citations.
Papers
More filters
Journal ArticleDOI
Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study
Ercan Ok,Gulay Asci,Huseyin Toz,Ebru Sevinc Ok,Fatih Kircelli,Mümtaz Yilmaz,Ender Hur,Meltem Sezis Demirci,Cenk Demirci,Soner Duman,Ali Basci,Siddig Momin Adam,Ismet Onder Isik,Murat Zengin,Gultekin Suleymanlar,Mehmet Emin Yilmaz,Mehmet Ozkahya +16 more
TL;DR: The composite of all-cause mortality and nonfatal cardiovascular event rate was not different in the OL-HDF and in the high-flux HD groups and, in a post hoc analysis, OL-hDF treatment with substitution volumes over 17.4 L was associated with better cardiovascular and overall survival.
Journal ArticleDOI
Effect of Fluid Management Guided by Bioimpedance Spectroscopy on Cardiovascular Parameters in Hemodialysis Patients: A Randomized Controlled Trial
Ender Hur,Mehmet Usta,Huseyin Toz,Gulay Asci,Peter Wabel,Serdar Kahvecioglu,Meral Kayıkçıoğlu,Meltem Sezis Demirci,Mehmet Ozkahya,Soner Duman,Ercan Ok +10 more
TL;DR: Assessment of fluid overload with bioimpedance spectroscopy provides better management of fluid status, leading to regression of left ventricular mass index, decrease in blood pressure, and improvement in arterial stiffness.
Journal ArticleDOI
Strict volume control normalizes hypertension in peritoneal dialysis patients
TL;DR: Findings show that normal BP can be achieved by severe salt restriction combined with increased UF in the majority of CAPD patients, but also by a decrease in residual renal function and Kt/V index.
Journal ArticleDOI
The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis
Meral Kayıkçıoğlu,Murat Tumuklu,Mehmet Ozkahya,Oner Ozdogan,Gulay Asci,Soner Duman,Huseyin Toz,Levent Can,Ali Basci,Ercan Ok +9 more
TL;DR: It is suggested that salt restriction and reduced prescription of antihypertensive drugs may limit LV hypertrophy, better preserve LV functions and reduce intradialytic hypotension in HD patients.
Journal ArticleDOI
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients
Peter Willeit,Lena Tschiderer,Elias Allara,Kathrin Reuber,Lisa Seekircher,Lu Gao,Ximing Liao,Eva Lonn,Hertzel C. Gerstein,Salim Yusuf,Frank P. Brouwers,Folkert W. Asselbergs,Wiek H. van Gilst,Sigmund A. Anderssen,Diederick E. Grobbee,John J.P. Kastelein,Frank L.J. Visseren,George Ntaios,Apostolos I. Hatzitolios,Christos Savopoulos,Pythia T. Nieuwkerk,Erik S.G. Stroes,Matthew Walters,Peter Higgins,Jesse Dawson,Paolo Gresele,Giuseppe Guglielmini,Rino Migliacci,Marat V. Ezhov,Maya S. Safarova,T.V. Balakhonova,Eiichi Sato,Mayuko Amaha,Tsukasa Nakamura,Kostas Kapellas,Lisa Jamieson,Michael R. Skilton,James A. Blumenthal,Alan L. Hinderliter,Andrew Sherwood,Patrick Smith,Michiel A. Van Agtmael,Peter Reiss,Marit G.A. Van Vonderen,Stefan Kiechl,Gerhard Klingenschmid,Matthias Sitzer,Coen D.A. Stehouwer,Heiko Uthoff,Zhiyong Zou,Ana Rosa Cunha,Mario Fritsch Neves,Miles D. Witham,Hyun Woong Park,Moo Sik Lee,Jang Ho Bae,Enrique Bernal,K. Wachtell,Sverre E. Kjeldsen,Michael H. Olsen,David Preiss,Naveed Sattar,Edith Beishuizen,Menno V. Huisman,Mark A. Espeland,Caroline Schmidt,Stefan Agewall,Ercan Ok,Gulay Asci,Eric de Groot,Muriel P.C. Grooteman,Peter J. Blankestijn,Michiel L. Bots,Michael J. Sweeting,Simon G. Thompson,Matthias W. Lorenz +75 more
TL;DR: The extent of intervention effects on cIMT progression predicted the degree of CVD risk reduction, providing a missing link supporting the usefulness of cIMt progression as a surrogate marker for CVDrisk in clinical trials.